絞り込み

16355

広告

「abatacept」の検索結果

3040件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Challenges and Opportunities in Targeting the CD28/CTLA-4 Pathway in Transplantation and Autoimmunity.

Abatacept therapy reduces CD28+CXCR5+ follicular helper-like T cells in patients with rheumatoid arthritis.

Interleukin-10-producing LAG3(+) regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis.

Re-administration of abatacept for the control of articular symptoms of rheumatoid arthritis during anti-tuberculous therapy.

Emerging treatments for ulcerative colitis: a systematic review.

Update on the management of giant cell arteritis.

Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.

Memory B Cells and Response to Abatacept in Rheumatoid Arthritis.

Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project.

Recessively Inherited Lrba Mutations Cause Autoimmunity Presenting as Neonatal Diabetes.

Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis.

Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price Trends.

New Structural Formats of Therapeutic Antibodies for Rheumatology.

Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors.

Juvenile Idiopathic Arthritis.

Biologic Disease-modifying Antirheumatic Drug (bDMARD)-induced Neutropenia: A Registry from a Retrospective Cohort of Patients with Rheumatic Diseases Treated with 3 Classes of Intravenous bDMARD.

BK viruria and viremia in children with systemic lupus erythematosus.

Clinical trials in minimal change disease.

FcRL4(+) B-cells in salivary glands of primary Sjögren's syndrome patients.

Head-to-head comparison of aggressive conventional therapy and three biological treatments and comparison of two de-escalation strategies in patients who respond to treatment: study protocol for a multicenter, randomized, open-label, blinded-assessor, phase 4 study.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります